JohnsonandJohnson | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Science Technology The Market Buzz Your Environment

Johnson & Johnson’s COVID-19 Vaccine Prevents Illness in Hamsters

Rebecca Urena09/04/202009/04/2020

3347

Johnsons & Johnson’s (NYSE: JNJ) possible coronavirus vaccine, currently being tested, has prevented serious diseases in a limited group of Syrian golden hamsters, according to the company. The multinational...

Healthcare Investing News Market News

Johnson & Johnson to Buy Momenta Pharmaceutical for $6.5 Billion

Rebecca Urena08/19/2020

3641

Johnson & Johnson (NYSE: JNJ) announced Wednesday it would be purchasing Momenta Pharmaceuticals for USD6.5 Billion in cash as it strives to grow its portfolio of drugs for autoimmune...

Biotechnology Healthcare Investing News Life Style Market News Pharmaceutical The Market Buzz Your Environment

Johnson & Johnson to Deliver U.S 100 Million Doses of Coronavirus Vaccine

Rebecca Urena08/05/2020

5430

Johnson & Johnson (NYSE: JNJ) revealed Wednesday that it has reached an agreement with the U.S. to provide 100 million doses of it COVID-19 vaccine for a sum of...

Healthcare Investing News Market News Technology The Market Buzz

J&J Profit Plummets 35%

Rebecca Urena07/16/202007/16/2020

4863

Johnson & Johnson (NYSE: JNJ) second quarter profit plummets 35% amid the coronavirus pandemic. The lack of demand for beauty products and medical equipment has taken a toll on...

Biotechnology Healthcare Investing News Life Style Market News Your Environment

Johnson & Johnson Prepares to Commence Human Trials for Its COVID-19 Vaccine

Rebecca Urena06/10/2020

4549

Johnson & Johnson (NYSE: JNJ) revealed Wednesday that it will be commencing early-stage human trials for its budding coronavirus vaccine set to start in late July, sooner than the...

AI Breaking News Cloud Computing Gadgets LIVE - Floor of the NYSE! Market News Technology The Buzz TV The Market Buzz Top Videos Travel Video

January 25, 2019 Weekly Wrap up LIVE from the floor of the NYSE

financial buzz01/25/201902/01/2019

19085

9

On Monday markets were closed for the Martin Luther King Jr. holiday, and on Tuesday the existing home sales report for December fell a larger than expected 6.4% to...

Tag: JohnsonandJohnson

Johnson & Johnson’s COVID-19 Vaccine Prevents Illness in Hamsters

Johnson & Johnson to Buy Momenta Pharmaceutical for $6.5 Billion

Johnson & Johnson to Deliver U.S 100 Million Doses of Coronavirus Vaccine

J&J Profit Plummets 35%

Johnson & Johnson Prepares to Commence Human Trials for Its COVID-19 Vaccine

January 25, 2019 Weekly Wrap up LIVE from the floor of the NYSE

ABOUT US

INSTAGRAM

Tweets